Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manal A Abbas

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
Therapeutic Advances in Hematology|February 13, 2026
Endothelial dysfunction and cardiac damage indicators in patients with β-thalassemia major under iron-chelation therapyOla M Al-Sanabra, Manal A Abbas, Wafà J Hazà, et al.
Basic & Clinical Pharmacology & Toxicology|January 26, 2026
Diosmin Alleviates Pain via Mechanisms Involving Acetylcholinesterase and TRPV1 Inhibition: An In Silico and In Vivo StudyAya Y Al-Kabariti, Belal O Al-Najjar, Mohammad Alsalem, et al.
Balkan Medical Journal|March 5, 2020
Antinociceptive Action of <i>Moringa peregrina</i> is Mediated by an Interaction with α<sub>2</sub>-Adrenergic ReceptorSahar M. Jaffal, Belal O. Al-Najjar, Manal A. Abbas, et al.
Therapeutic Advances in Endocrinology and Metabolism|December 22, 2025
Endocrine complications in patients with β-thalassemia major receiving iron-chelation therapyOla M Al-Sanabra, Manal A Abbas, Abeer A Hazàa, et al.
Research in Pharmaceutical Sciences|July 21, 2025
Genistein potentiated the cytotoxic effect of entinostat in colorectal cancer cell linesNoura Abedalnaser Alqalalwah, Manal M Abbas, Manal A Abbas, et al.
Journal of Biomolecular Structure & Dynamics|January 8, 2025
Novel acridone derivatives as potential P2Y<sub>12</sub> receptor inhibitors: integrating computational modeling and experimental analysisFadi G Saqallah, Belal O Al-Najjar, Aya Y Al-Kabariti, et al.
Drug Development Research|July 10, 2025
TRPC1 and TRPC5 in Colorectal Cancer: Mechanisms, Prognostic Markers, and Therapeutic TargetsManal A Abbas, Aya Y Al-Kabariti, Randa El-Rayyes, et al.
European Journal of Medicinal Chemistry|November 3, 2021
P2Y<sub>12</sub> antagonists: Approved drugs, potential naturally isolated and synthesised compounds, and related in-silico studiesBelal O Al-Najjar, Fadi G Saqallah, Manal A Abbas, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|July 15, 2025
Coagulation and Fibrinolysis Dysregulation in β-Thalassemia Major: Potential Impact of Splenectomy and Medications on Thrombotic RiskOla M Al-Sanabra, Manal A Abbas, Wafà J Hazà, et al.
RSC Medicinal Chemistry|February 27, 2023
QSAR, structure-based pharmacophore modelling and biological evaluation of novel platelet ADP receptor (P2Y<sub>12</sub>) antagonistBelal O Al-Najjar, Manal A Abbas, Obada A Sibai, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Therapeutic Advances in Hematology|February 13, 2026
Endothelial dysfunction and cardiac damage indicators in patients with β-thalassemia major under iron-chelation therapyOla M Al-Sanabra, Manal A Abbas, Wafà J Hazà, et al.
Basic & Clinical Pharmacology & Toxicology|January 26, 2026
Diosmin Alleviates Pain via Mechanisms Involving Acetylcholinesterase and TRPV1 Inhibition: An In Silico and In Vivo StudyAya Y Al-Kabariti, Belal O Al-Najjar, Mohammad Alsalem, et al.
Balkan Medical Journal|March 5, 2020
Antinociceptive Action of <i>Moringa peregrina</i> is Mediated by an Interaction with α<sub>2</sub>-Adrenergic ReceptorSahar M. Jaffal, Belal O. Al-Najjar, Manal A. Abbas, et al.
Therapeutic Advances in Endocrinology and Metabolism|December 22, 2025
Endocrine complications in patients with β-thalassemia major receiving iron-chelation therapyOla M Al-Sanabra, Manal A Abbas, Abeer A Hazàa, et al.
Research in Pharmaceutical Sciences|July 21, 2025
Genistein potentiated the cytotoxic effect of entinostat in colorectal cancer cell linesNoura Abedalnaser Alqalalwah, Manal M Abbas, Manal A Abbas, et al.
Journal of Biomolecular Structure & Dynamics|January 8, 2025
Novel acridone derivatives as potential P2Y<sub>12</sub> receptor inhibitors: integrating computational modeling and experimental analysisFadi G Saqallah, Belal O Al-Najjar, Aya Y Al-Kabariti, et al.
Drug Development Research|July 10, 2025
TRPC1 and TRPC5 in Colorectal Cancer: Mechanisms, Prognostic Markers, and Therapeutic TargetsManal A Abbas, Aya Y Al-Kabariti, Randa El-Rayyes, et al.
European Journal of Medicinal Chemistry|November 3, 2021
P2Y<sub>12</sub> antagonists: Approved drugs, potential naturally isolated and synthesised compounds, and related in-silico studiesBelal O Al-Najjar, Fadi G Saqallah, Manal A Abbas, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|July 15, 2025
Coagulation and Fibrinolysis Dysregulation in β-Thalassemia Major: Potential Impact of Splenectomy and Medications on Thrombotic RiskOla M Al-Sanabra, Manal A Abbas, Wafà J Hazà, et al.
RSC Medicinal Chemistry|February 27, 2023
QSAR, structure-based pharmacophore modelling and biological evaluation of novel platelet ADP receptor (P2Y<sub>12</sub>) antagonistBelal O Al-Najjar, Manal A Abbas, Obada A Sibai, et al.
Pageof 4